JPRN-UMIN000019969已完成未知
Insulin glargine 300 U/ml versus insulin degludec 100 U/ml in type 2 diabetic patients treated with basal-bolus insulin therapy - Insulin glargine 300 U/ml versus insulin degludec 100 U/ml in type 2 diabetic patients treated with basal-bolus insulin therapy
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •- treated with anti-diabetic agents other than insulin - difficult to perform self-monitoring of blood glucose - severe hepatic, renal and/or cardiac disease - hypersensitivity to insulin degludec and/or insulin glargine - pregnant or breast-feeding females. - Patients who are judged by the investigator to be inappropriate for this study for any other reason.
研究者
相似试验
招募中
不适用
Comparison of insulin glargine and insulin degludec in type 2 diabetes by continuous glucose monitoring systemtype 2 diabetesJPRN-UMIN000010715Mie Chuo Medical Center30
已完成
不适用
Comparison of Insulin degludec vs. Insulin glargine using continuous glucose monitoring (CGM): Crossover studyJPRN-UMIN000010847Ichinomiyanishi Hospital16
已完成
不适用
Effects of Insulin Degludec versus Insulin Glargine in basal-bolus treatment in type 2 diabetes assessed by continuous glucose monitoring systemtype 2 diabetesJPRN-UMIN000010248Juntendo University Graduate School of Medicine30
尚未招募
不适用
Comparison study between insulin glargine and decludec on the glucose fluctuation in Type 2 diabetic patients treated with basal insulin and oral hypoglycemic agents.JPRN-UMIN000012138Kyorin University of Medicine30
已完成
不适用
Comparison of Insulin glargine 300 U/ml + SGLT2 inhibitor therapy (Tofogliflozin 20 mg vs. Ipragliflozin 50 mg) using continuous glucose monitoring (CGM): randomised crossover studytype 2 diabetesJPRN-UMIN000023972General Inuyamachuo Hospital35